Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs
NAR Cancer · 11.03.2023 · 5 (2)
DOI: 10.1093/narcan/zcad027 ↗Kurz gefasst
Fachartikel in der Zeitschrift NAR Cancer, online erschienen am 01.06.2023. Verfasst von Spencer Arnesen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, DOD Breast Cancer Research Program Expansion Award, Huntsman Cancer Institute.
Abstract (Originalsprache)
Estrogen receptor α (ER) mutations occur in up to 30% of metastatic ER-positive breast cancers. Recent data has shown that ER mutations impact the expression of thousands of genes not typically regulated by wildtype ER. While the majority of these altered genes can be explained by constant activity of mutant ER or genomic changes such as altered ER binding and chromatin accessibility, as much as 33% remain unexplained, indicating the potential for post-transcriptional effects. Here, we explored the role of microRNAs in mutant ER-driven gene regulation and identified several microRNAs that are dysregulated in ER mutant cells. These differentially regulated microRNAs target a significant portion of mutant-specific genes involved in key cellular processes. When the activity of microRNAs is altered using mimics or inhibitors, significant changes are observed in gene expression and cellular proliferation related to mutant ER. An in-depth evaluation of miR-301b led us to discover an important role for PRKD3 in the proliferation of ER mutant cells. Our findings show that microRNAs contribute to mutant ER gene regulation and cellular effects in breast cancer cells.
Autor:innen und Institutionen
- Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
- Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA.
ORCID-Profile: Spencer Arnesen, Jason Gertz
Förderung
- NCI NIH HHS
- DOD Breast Cancer Research Program Expansion Award
- Huntsman Cancer Institute
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Arnesen, S., Polaski, J. T., Blanchard, Z., Osborne, K. S., Welm, A. L., O'Connell, R. M., & Gertz, J. (2023). Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs. NAR Cancer, 5(2). https://doi.org/10.1093/narcan/zcad027
Vancouver
Arnesen S, Polaski JT, Blanchard Z, Osborne KS, Welm AL, O'Connell RM, et al. Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs. NAR Cancer. 2023;5(2). doi:10.1093/narcan/zcad027
BibTeX
@article{Arnesen2023,
author = {Arnesen, Spencer and Polaski, Jacob T and Blanchard, Zannel and Osborne, Kyle S and Welm, Alana L and O'Connell, Ryan M and Gertz, Jason},
title = {Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs},
journal = {NAR Cancer},
year = {2023},
volume = {5},
number = {2},
doi = {10.1093/narcan/zcad027}
}
EUVIMED